Skip to main content
Premium Trial:

Request an Annual Quote

Reinhard Schneider, Richard Gill, Howard Berke, Michael McManus, Michael Milburn, Seymour Mong

Premium

Lion Bioscience of Heidelberg, Germany, has tapped Reinhard Schneider for the position of chief information officer.

Schneider is a Lion co-founder. He joined the company as vice president of bioinformatics in 1997 and became CEO of Lion Bioscience Research of Cambridge, Mass., in 1999.

 

AnVil Informatics, based in Lowell, Mass., has appointment Richard Gill as president and CEO. Former CEO Howard Berke will remain as a board director and former president Michael McManus will now serve as executive vice president and COO.

Prior to joining AnVil, Gill was president and CEO of ActiveCyte and president and COO of Genome Therapeutics.

 

Michael Milburn, most recently vice president of structural biology at Structural GenomiX, where he directed the bioinformatics, computational chemistry and crystallography groups, has been named senior vice president and head of research at Plexxikon of Berkeley, Calif.

 

Seymour Mong, a co-founder of Structural Bioinformatics, has joined BioStratum of Research Triangle Park, NC, as vice president of research.

As vice president of biotechnology at Structural Bioinformatics, Mong was responsible for drug target validation and drug discovery through a computational and data based approach.

Filed under

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.